BlackRock Fund Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$87.5M Buy
2,663,371
+372,992
+16% +$12.2M 0.02% 1307
2016
Q3
$72.2M Buy
2,290,379
+285,152
+14% +$8.99M 0.01% 1326
2016
Q2
$56.4M Buy
2,005,227
+114,715
+6% +$3.23M 0.01% 1406
2016
Q1
$68.7M Sell
1,890,512
-12,043
-0.6% -$438K 0.02% 1237
2015
Q4
$76.1M Buy
1,902,555
+107,633
+6% +$4.31M 0.02% 1179
2015
Q3
$51.1M Buy
1,794,922
+62,943
+4% +$1.79M 0.01% 1409
2015
Q2
$57.1M Buy
1,731,979
+32,165
+2% +$1.06M 0.01% 1434
2015
Q1
$48.9M Buy
1,699,814
+99,056
+6% +$2.85M 0.01% 1519
2014
Q4
$43.6M Buy
1,600,758
+149,456
+10% +$4.07M 0.01% 1549
2014
Q3
$30.9M Sell
1,451,302
-48,298
-3% -$1.03M 0.01% 1670
2014
Q2
$33.7M Sell
1,499,600
-36,113
-2% -$811K 0.01% 1672
2014
Q1
$38.8M Sell
1,535,713
-130
-0% -$3.29K 0.01% 1575
2013
Q4
$35.3M Buy
1,535,843
+45,430
+3% +$1.04M 0.01% 1633
2013
Q3
$28.4M Buy
1,490,413
+192,053
+15% +$3.66M 0.01% 1732
2013
Q2
$18.7M Buy
+1,298,360
New +$18.7M 0.01% 1899